Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 148
Filter
1.
J Cardiothorac Surg ; 19(1): 263, 2024 Apr 24.
Article in English | MEDLINE | ID: mdl-38659034

ABSTRACT

BACKGROUND: Post-Operative Atrial Fibrillation (POAF) is the most frequent complication of cardiac surgery and is associated with reduced survival, increased rates of cognitive changes and cerebrovascular accidents, heart failure, renal dysfunction, infection, length of stay and hospital costs. Cardiac tamponade although less common, carries high morbidity and mortality. Shed mediastinal blood in the pericardial space is a major source of intrapericardial oxidative stress and inflammation that triggers POAF. The utilisation of a posterior pericardiotomy (PP) aims to shunt blood from pericardium into the pleural space and have a role in the prevention of POAF as well as cardiac tamponade. METHODS: 2168 patients had undergone isolated Coronary Artery Bypass Grafting at Royal Hobart Hospital from 2008 to 2022. They were divided into PP group vs. control group. Patient baseline demographics, intraoperative data and post-operative outcomes were reviewed retrospectively. RESULTS: Total incidence of new POAF and cardiac tamponade was 24% and 0.74% respectively. Primary outcome of both the incidence of POAF (20.2% vs. 26.3%, p < 0.05) and Cardiac Tamponade (0% vs. 1.1%, p < 0.05) were less in the pericardiotomy group. A subgroup analysis of patients with recent myocardial infarction showed reduced incidence of POAF in the PP group (p < 0.05). Increasing age, Body Mass Index, poor left ventricular ejection fraction (EF < 30%) and return to theatre were independent predictors of developing POAF. There were similar rates of return to theatre for bleeding however, no cases of tamponade in the pericardiotomy group. There were no complications attributable to left posterior pericardiotomy and the time added to the duration of surgery was minimal. CONCLUSION: Posterior pericardiotomy is associated with a significant reduction in the incidence of POAF and cardiac tamponade which is safe and efficient.


Subject(s)
Atrial Fibrillation , Cardiac Tamponade , Coronary Artery Bypass , Pericardiectomy , Postoperative Complications , Humans , Cardiac Tamponade/prevention & control , Cardiac Tamponade/etiology , Cardiac Tamponade/epidemiology , Male , Female , Atrial Fibrillation/prevention & control , Atrial Fibrillation/etiology , Atrial Fibrillation/surgery , Retrospective Studies , Coronary Artery Bypass/adverse effects , Coronary Artery Bypass/methods , Pericardiectomy/methods , Postoperative Complications/prevention & control , Postoperative Complications/epidemiology , Middle Aged , Aged , Incidence
2.
Cardiol Young ; 34(4): 765-770, 2024 Apr.
Article in English | MEDLINE | ID: mdl-37822207

ABSTRACT

OBJECTIVE: Pericardial tamponade, which increases postoperative mortality and morbidity, is still not uncommon after paediatric cardiac surgery. We considered that posterior pericardiotomy may be a useful and safe technique in order to reduce the incidence of early and late pericardial tamponade. Herein, we present our experience with creation of posterior pericardial window following congenital cardiac surgical procedures. METHODS: This retrospective study evaluated 229 patients who underwent paediatric cardiac surgical procedures between June 2021 and January 2023. A posterior pericardial window was created in all of the patients. In neonates and infants, pericardial window was performed at a size of 2x2 cm, whereas a 3x3 cm connection was established in elder children and young adults. A curved chest tube was placed and positioned at the posterolateral pericardiophrenic sinus. An additional straight anterior mediastinal chest tube was also inserted in every patient. Transthoracic echocardiographic evaluations were performed daily to assess postoperative pericardial effusion. RESULTS: A total of 229 (135 male, 94 female) patients were operated. Mean age and body weight were 24.2 ± 26.7 months and 10.2 ± 6.7 kg, respectively. Eight (3.5%) of the patients were neonates where 109 (47.6%) were infants and 112 (48.9%) were in childhood. Fifty-two (22.7%) re-do operations were performed. Six (2.6%) patients underwent postoperative surgical re-exploration due to surgical site bleeding. Any early or late pericardial tamponade was not encountered in the study group. CONCLUSIONS: Posterior pericardial window is an effective and safe technique in order to prevent both the early and late pericardial tamponade after congenital cardiac surgery.


Subject(s)
Cardiac Surgical Procedures , Cardiac Tamponade , Pericardial Effusion , Infant, Newborn , Humans , Male , Female , Child , Cardiac Tamponade/etiology , Cardiac Tamponade/prevention & control , Retrospective Studies , Pericardial Effusion/etiology , Pericardial Effusion/prevention & control , Pericardial Effusion/surgery , Treatment Outcome , Cardiac Surgical Procedures/adverse effects
3.
Europace ; 26(1)2023 12 28.
Article in English | MEDLINE | ID: mdl-38163951

ABSTRACT

AIMS: Pericardial tamponade (PT) is the most frequent severe complication during electrophysiology (EP) procedures and requires immediate, co-ordinated, and effective treatment. However, multiple aspects of PT treatment are either not standardized or are under ongoing debate. METHODS AND RESULTS: An online questionnaire consisting of 26 multiple-choice questions was sent out to the European Heart Rhythm (EHRA) Research Network and also distributed via social media outputs. The EHRA survey was conducted between May and June 2023. A total of 213 replies were received from European (87%) and non-European countries. Ninety per cent of all participants perform interventions in dedicated EP labs equipped with different ablation platforms. In case of PT, most participants use X-ray as the main imaging modality guiding pericardial puncture, predominantly aiming for an anterior puncture site. Sheaths of different sizes are introduced into the pericardial space (84.3%), followed by a pigtail catheter. Application of protamine is an established but variable step in the majority (84.6%). Novel oral anticoagulants (NOAC) antidotes are not used by 73.3% of participants, while 15.2% routinely apply them. Re-transfusion of aspirated blood is performed by 72.1% [before protamine administration (18.2%), after protamine administration (13.5%), if pericardial effusion cannot be controlled (40.4%)]. A total of 72.4% re-transfuse without blood filter systems. A decision for surgical intervention is mostly taken if bleeding continues despite all interventional measures. CONCLUSION: The current survey demonstrates that the management of PT is heterogeneous among centres. The findings of this survey may help to guide operators in their treatment and decisions in the setting of PT.


Subject(s)
Anticoagulants , Cardiac Tamponade , Humans , Anticoagulants/therapeutic use , Cardiac Tamponade/diagnostic imaging , Cardiac Tamponade/etiology , Cardiac Tamponade/prevention & control , Surveys and Questionnaires , Protamines , Electrophysiology
4.
Intern Emerg Med ; 16(5): 1391-1394, 2021 Aug.
Article in English | MEDLINE | ID: mdl-33475973

ABSTRACT

The clinical response to anakinra observed by this patient concurrently treated with antibiotics indirectly confirms the potentially pathogenic role of IL-1 in maintaining the pericardial disease and shows how IL-1 blockade might allow avoiding the pericardiocentesis procedure. The report supports the hypothesis that anakinra is an effective and safe tool in the early treatment of acute pericarditis of presumed bacterial origin nonresponding to targeted antibiotic therapy.


Subject(s)
Cardiac Tamponade/prevention & control , Interleukin 1 Receptor Antagonist Protein/pharmacology , Pericarditis/drug therapy , Aged, 80 and over , Anti-Bacterial Agents/therapeutic use , Cardiac Tamponade/drug therapy , Humans , Interleukin 1 Receptor Antagonist Protein/therapeutic use , Male , Pericarditis/physiopathology , Sepsis/drug therapy , Sepsis/prevention & control , Staphylococcal Infections/complications , Staphylococcal Infections/drug therapy
5.
J Card Surg ; 35(6): 1247-1252, 2020 Jun.
Article in English | MEDLINE | ID: mdl-32302035

ABSTRACT

BACKGROUND AND AIM OF STUDY: Placement of temporary epicardial pacing wires (TEPW) is common practice in cardiac surgery. Removal of TEPW in the postoperative period can lead to serious bleeding necessitating surgical intervention and conferring high morbidity. The purpose of this study is to determine the incidence of TEPW removal complications. METHODS: A retrospective review of all major cardiac operations at our institution from 2005 to 2016 was conducted. Patients were identified using the Maritime Heart Center Database. We reviewed preoperative, intra-operative, and postoperative characteristics of patients who returned to the operating room more than or equal to 3 days after their index operation to identify those who had bleeding and/or tamponade as a consequence of TEPW removal and any subsequent morbidity. RESULTS: A total of 11 754 patients underwent cardiac surgery at our institution between 2005 and 2016. Of these patients, 88 (0.75%) went back to the operating theater for bleeding and/or tamponade more than or equal to 3 days from their initial index operation. Of these, 11 (0.09%) were secondary to TEPW removal where two (0.017%) suffered irreversible anoxic brain injury. All 11 patients were on antiplatelet therapy with the addition of either deep venous thrombosis (DVT) prophylaxis or therapeutic anticoagulation, which is the standard of care at our institution. CONCLUSIONS: Bleeding complications following TEPW removal are rare but have significant consequences including increased hospital length of stay, resource utilization, and morbidity. Standardized practice to address antiplatelet, DVT prophylaxis, and anticoagulation before removal may help further reduce the incidence of serious bleeding events.


Subject(s)
Cardiac Surgical Procedures , Cardiac Tamponade/epidemiology , Cardiac Tamponade/etiology , Device Removal/adverse effects , Pacemaker, Artificial , Postoperative Complications/etiology , Adult , Aged , Anticoagulants/administration & dosage , Cardiac Tamponade/prevention & control , Female , Hemorrhage/epidemiology , Hemorrhage/etiology , Hemorrhage/prevention & control , Humans , Incidence , Male , Middle Aged , Platelet Aggregation Inhibitors/administration & dosage , Postoperative Complications/epidemiology , Postoperative Complications/prevention & control , Postoperative Period , Preoperative Care , Retrospective Studies
6.
Ann Cardiol Angeiol (Paris) ; 68(6): 439-442, 2019 Dec.
Article in French | MEDLINE | ID: mdl-31676032

ABSTRACT

Transcatheter aortic valve (TAVI) is the treatment of choice in patients with severe symptomatic aortic stenosis at high surgical risk. Recent data have also shown favorable results in patients considered to have an intermediate operative risk, which broadens the application of this new technology. Despite its success, the TAVI procedure has been associated with life-threatening complications. Advances in preoperative screening and patient selection have reduced the incidence of these complications. When these complications occur, early recognition and rapid management are essential. The purpose of this review is to describe non-rhythmic mechanical complications attributable to TAVI procedures with their predictive factors, how to prevent and manage them.


Subject(s)
Aortic Valve Stenosis/surgery , Postoperative Complications/therapy , Transcatheter Aortic Valve Replacement/adverse effects , Vascular Diseases/prevention & control , Aortic Rupture/etiology , Aortic Rupture/prevention & control , Aortic Valve Insufficiency/etiology , Aortic Valve Insufficiency/prevention & control , Brain Ischemia/etiology , Brain Ischemia/prevention & control , Cardiac Tamponade/etiology , Cardiac Tamponade/prevention & control , Coronary Occlusion/etiology , Coronary Occlusion/prevention & control , Humans , Patient Selection , Postoperative Complications/etiology , Vascular Calcification/complications , Vascular Diseases/etiology
7.
J Vet Emerg Crit Care (San Antonio) ; 29(4): 413-417, 2019 Jul.
Article in English | MEDLINE | ID: mdl-31228330

ABSTRACT

OBJECTIVE: To describe the use of pericardial catheters in dogs with pericardial effusion (PE), and detail any associated adverse events. DESIGN: Retrospective study. SETTING: University teaching hospital. ANIMALS: Eighteen client-owned dogs that had pericardial catheters placed for pericardial fluid drainage between May 2007 and January 2015. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: All pericardial catheters were placed within 5 hours of presentation, usually within 1 hour (median 72.5 min, range 45-300 min). Ten of 18 cases were sedated with butorphanol, and 4 with additional midazolam. Four had pericardial catheters positioned for single drainage only and were immediately removed. The other 14 pericardial catheters remained in situ for a median of 18 hours (range 2-88 h). Ten of the remaining 14 cases were redrained after pericardial catheter placement. The main adverse events reported were new arrhythmias in 6/18 cases, with 4 of these 6 patients being administered anti-arrhythmic therapy. No infectious or functional complications were reported. Ten patients were discharged, 1 died and 7 were euthanized. CONCLUSIONS: Thoracic drainage catheters inserted into the pericardial space via a modified-Seldinger technique can be positioned in dogs to aid management of PEs. The main associated adverse event is arrhythmia. Minimal sedation is required for placement, and dogs tend not to require postprocedural analgesia. Catheters can remain in situ for repeated drainage, potentially decreasing staffing time requirement and repeat sedation. Their use is associated with a rate of arrhythmia requiring treatment of 22%, compared to that of needle pericardiocentesis alone at 13%. They are easy to position using equipment available in many facilities.


Subject(s)
Cardiac Catheters/veterinary , Cardiac Tamponade/veterinary , Dog Diseases/therapy , Drainage/veterinary , Pericardial Effusion/veterinary , Animals , Cardiac Tamponade/prevention & control , Dogs , Female , Humans , Male , Pericardial Effusion/complications , Pericardial Effusion/therapy , Pericardiocentesis/adverse effects , Pericardium , Retrospective Studies
8.
Scand Cardiovasc J ; 53(2): 104-109, 2019 Apr.
Article in English | MEDLINE | ID: mdl-30835565

ABSTRACT

OBJECTIVES: To ascertain whether extended chest tube drainage decreases the occurrence of late tamponade after cardiac surgery. DESIGN: All patients undergoing cardiac surgery at the Tampere University Heart Hospital, Tampere, Finland, between the 23rd of October 2015 and the 17th of August 2016 were included. The first 260 consecutive patients were treated according to a short drainage protocol, in which the mediastinal chest tubes were removed during the first postoperative day unless producing >50ml/h, and the following 224 consecutive patients by an extended drainage protocol, in which the mediastinal chest tubes were kept at least until the second postoperative day, and thereafter if producing >50ml/4h. The incidence of late tamponade and the length and course of postoperative hospitalization, including the development of complications, were compared. RESULTS: The occurrence of late cardiac tamponade was 8.8% following the short drainage protocol and 3.6% after the extended drainage protocol, p = .018. There were no statistically significant differences in the demographics, medical history, or the procedures performed between the study groups. The in-hospital mortality rate was 3.5%, the stroke rate was 2.1%, and the deep sternal wound infection rate was 1.7%, with no statistically significant differences between the groups. There were no differences in the need for reoperations for bleeding, infection rate, need for pleurocentesis, occurrence of atrial fibrillation, or the length of hospitalization between the groups. CONCLUSIONS: Longer mediastinal chest tube drainage after cardiac surgery is associated with a significantly lower incidence of late cardiac tamponade.


Subject(s)
Cardiac Surgical Procedures , Cardiac Tamponade/prevention & control , Chest Tubes , Drainage/instrumentation , Aged , Cardiac Surgical Procedures/adverse effects , Cardiac Surgical Procedures/mortality , Cardiac Tamponade/diagnosis , Cardiac Tamponade/mortality , Drainage/adverse effects , Drainage/mortality , Female , Finland/epidemiology , Humans , Incidence , Male , Prospective Studies , Risk Factors , Time Factors , Treatment Outcome
9.
J Invasive Cardiol ; 31(4): E69-E72, 2019 04.
Article in English | MEDLINE | ID: mdl-30927540

ABSTRACT

BACKGROUND: The objective of this study is to review acupuncture-related cardiac complications, such as infective endocarditis (IE), cardiac tamponade (CT), pericarditis, and cardiac rupture, as there is no known reported literature to determine the burden of cardiac adverse events due to acupuncture. METHODS: Structured computerized databases were searched using the special Medical Subject Heading (MeSH). Manual search using the references of relevant articles was also performed. RESULTS: A total of 133 articles were initially retrieved, but careful reading resulted in only 30 cases of relevant cardiac adverse events. There were 8 articles of infective complications (mostly IE), while 22 articles of CT have been reported to date. The diagnoses were made with echocardiography and patients were treated with intravenous antibiotics. The source of the infection was mostly localized to acupuncture needle prick sites, such as earlobes and legs. Mortality rate for post-acupuncture CT was not significantly higher than infective cardiac complication (Pearson's Chi-square = 0.559; likelihood ratio = 0.553). However, the weighted percentage of death was about 80% in CT vs only 20% mortality for infective cardiac complications. On the other hand, CT was the most common presentation when the needle pricks were close to the heart, and had a clinical presentation of hypotension and venous distention. CONCLUSIONS: Although the universally reported complications of acupuncture are low, and the procedure itself has been deemed low risk in acupuncture-related literature, these cardiac complications are alarming. To avoid these potentially catastrophic consequences, more education needs to be done for adopting safer techniques.


Subject(s)
Acupuncture Therapy/adverse effects , Cardiac Tamponade , Endocarditis , Heart Rupture , Pericarditis , Acupuncture Therapy/methods , Cardiac Tamponade/etiology , Cardiac Tamponade/prevention & control , Endocarditis/etiology , Endocarditis/prevention & control , Heart Rupture/etiology , Heart Rupture/prevention & control , Humans , Pericarditis/etiology , Pericarditis/prevention & control , Risk Adjustment , Risk Factors
10.
G Ital Cardiol (Rome) ; 19(4): 248-259, 2018 Apr.
Article in Italian | MEDLINE | ID: mdl-29912241

ABSTRACT

Acute pericarditis is not uncommon in clinical practice and may occur either as isolated disease or as a manifestation of another disease (known or still unknown). The etiology is varied and complex and a clinically-oriented approach to management is possible by identifying initial presentation features of high risk (risk of complications or specific disease: fever >38°C, subacute course without acute chest pain, large pericardial effusion, cardiac tamponade, and lack of response to empiric anti-inflammatory therapy), that suggest admission and additional diagnostic evaluation. In any case, a prompt anti-inflammatory therapy at full doses till remission is warranted to prevent complicated and prolonged courses. In this paper, we will try to clarify common doubts and outline evidence-based approaches to the diagnosis, therapy and follow-up of these patients.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Cardiac Tamponade/therapy , Clinical Decision-Making , Pericardial Effusion/therapy , Pericarditis/therapy , Practice Guidelines as Topic , Cardiac Tamponade/prevention & control , Cardiologists , Combined Modality Therapy , Disease Progression , Early Diagnosis , Evidence-Based Medicine , Female , Humans , Italy , Male , Pericardial Effusion/prevention & control , Pericardiocentesis/methods , Pericarditis/diagnosis , Pericarditis/mortality , Prognosis , Risk Assessment , Severity of Illness Index , Societies, Medical , Survival Rate , Treatment Outcome
11.
Interv Cardiol Clin ; 7(2): 243-252, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29526292

ABSTRACT

Major procedural complications related to left atrial appendage occlusion (LAAO) are relatively infrequent but may be associated with major morbidity and mortality. LAAO operators should be knowledgeable about these potential complications. Prompt recognition and treatment are necessary to avoid rapid deterioration and dire consequences. With stringent guidelines on operator training, competency requirements, and procedural-technical refinements, LAAO can be performed safely with low complication rates. This article focuses on commonly used devices, as well as prevention, treatment, and management of complications of LAOO.


Subject(s)
Atrial Appendage/surgery , Atrial Fibrillation/surgery , Cardiac Catheterization/adverse effects , Septal Occluder Device/adverse effects , Atrial Appendage/physiopathology , Atrial Fibrillation/mortality , Atrial Fibrillation/physiopathology , Cardiac Catheterization/methods , Cardiac Tamponade/epidemiology , Cardiac Tamponade/mortality , Cardiac Tamponade/prevention & control , Cardiac Tamponade/therapy , Comorbidity , Humans , Incidence , Pericardial Effusion/epidemiology , Pericardial Effusion/mortality , Pericardial Effusion/prevention & control , Pericardial Effusion/therapy , Perioperative Period , Practice Guidelines as Topic , Preceptorship/standards , Stroke/epidemiology , Stroke/mortality , Stroke/prevention & control , Stroke/therapy , Thrombosis/epidemiology , Thrombosis/mortality , Thrombosis/prevention & control , Thrombosis/therapy , Treatment Outcome
12.
Orv Hetil ; 159(5): 163-167, 2018 Feb.
Article in Hungarian | MEDLINE | ID: mdl-29376423

ABSTRACT

Acute pericardial tamponade is one of the most emergent clinical scenarios in cardiac surgery. With numerous causes in the background, pericardial tamponade can lead to cardiogenic shock and death. In modern diagnostic era, the recognition of pericardial tamponade is simple, but its management and the long-term effects can still be challenging. Without the detailed understanding of the pathophysiological pathways diagnostic and therapeutic management plans of pericardial tamponade is very difficult. The aim of this review was to give a complex picture of pericardial tamponade, from its role in medical history to pathophysiology and its significance in surgical experimental models. Orv Hetil. 2018; 159(5): 163-167.


Subject(s)
Cardiac Surgical Procedures/adverse effects , Cardiac Tamponade/prevention & control , Cardiac Tamponade/physiopathology , Cardiac Tamponade/diagnosis , Cardiac Tamponade/etiology , Echocardiography , Humans , Pericardial Effusion/etiology
13.
Rev. esp. anestesiol. reanim ; 64(9): 506-512, nov. 2017. ilus, tab
Article in Spanish | IBECS | ID: ibc-167090

ABSTRACT

Introducción. Las recomendaciones sobre la reanimación cardiopulmonar (RCP) enfatizan la calidad de las maniobras, en especial las compresiones torácicas (CT). Los dispositivos de retroalimentación podrían mejorar la calidad de las CT durante la RCP. El objetivo de este estudio fue evaluar la utilidad de un dispositivo lumínico simple como ayuda visual durante la RCP en un maniquí. Material y métodos. Veintidós mujeres pediatras que asistieron a un curso acreditado de RCP pediátrica realizaron, siguiendo un orden aleatorio, 2min de RCP en un maniquí sin y con la ayuda de un dispositivo luminoso simple, que emite destellos con una frecuencia de 100 ciclos por minuto. Se analizaron mediante un medidor validado de la calidad de las compresiones (CPRmeter®) las siguientes variables de las CT: profundidad, descompresiones, frecuencia, tiempo de RCP y porcentaje de compresiones. Resultados. Con el dispositivo luminoso, las participantes aumentaron la calidad media (60,23±54,50 vs. 79,24±9,80%; p=0,005), la profundidad (48,86±42,67 vs. 72,95±20,25%; p=0,036) y la frecuencia del masaje (35,82±37,54 vs. 67,09±31,95%; p=0,024). Conclusiones. Un dispositivo luminoso simple que parpadea a la frecuencia recomendada mejora la calidad de las CT realizadas por residentes de pediatría en un maniquí. Se debería evaluar la utilidad de este sistema de ayuda de la RCP en pacientes reales (AU)


Introduction. The recommendations on cardiopulmonary resuscitation (CPR) emphasize the quality of the manoeuvres, especially chest compressions (CC). Audiovisual feedback devices could improve the quality of the CC during CPR. The aim of this study was to evaluate the usefulness of a simple lighting device as a visual aid during CPR on a mannequin. Material and methods. Twenty-two paediatricians who attended an accredited paediatric CPR course performed, in random order, 2min of CPR on a mannequin without and with the help of a simple lighting device, which flashes at a frequency of 100 cycles per minute. The following CC variables were analyzed using a validated compression quality meter (CPRmeter®): depth, decompression, rate, CPR time and percentage of compressions. Results. With the lighting device, participants increased average quality (60.23±54.50 vs. 79.24±9.80%; P=.005), percentage in target depth (48.86±42.67 vs. 72.95±20.25%; P=.036) and rate (35.82±37.54 vs. 67.09±31.95%; P=.024). Conclusions. A simple light device that flashes at the recommended frequency improves the quality of CC performed by paediatric residents on a mannequin. The usefulness of this CPR aid system should be assessed in real patients (AU)


Subject(s)
Humans , Female , Adult , Heart Massage/instrumentation , Heart Massage/methods , Cardiopulmonary Resuscitation/education , Heart-Assist Devices , Cardiac Tamponade/epidemiology , Cardiac Tamponade/prevention & control , Internship and Residency , Internship and Residency/organization & administration
14.
Interact Cardiovasc Thorac Surg ; 24(6): 835-840, 2017 06 01.
Article in English | MEDLINE | ID: mdl-28329077

ABSTRACT

OBJECTIVES: Occurrence and risk factors of late postoperative pericardial effusions requiring invasive treatment, i.e. pretamponade and tamponade, following cardiac surgery are incompletely described in current literature. The purpose of this study was to define the incidence and presentation of late pretamponade and tamponade as well as to outline significant predisposing factors. METHODS: A cohort of 1356 consecutive cardiac surgery patients treated in a tertiary academic centre between January 2013 and December 2014 was followed up for 6 months after surgery. Pericardial effusion was considered late when presenting after the 7th postoperative day. The incidence, timing and risk factors, as well as symptoms and clinical findings associated with late pretamponade and tamponade in patients surviving at least 7 days was analysed. RESULTS: Of 1308 patients included in the analysis, 81 (6.2%) underwent invasive treatment for late postoperative pericardial effusion, 27 (2.1%) for pretamponade and 54 (4.1%) for tamponade, respectively, with a median delay of 11 (range 8-87) days after the primary operation. Haemodynamic instability was present in 34.6%, signs of cardiac chamber compression in 54.3% and subjective symptoms, mostly dyspnoea, in 56.8% of patients, respectively. Treated patients were younger, had lower EuroSCORE-II rating, less coronary disease, better cardiac function, higher preoperative haemoglobin values and had mostly undergone elective surgery involving cardiac valves. In multivariable analysis, independent risk factors were single valve surgery and high preoperative haemoglobin level, whereas age 60-69 years was associated with lower risk. CONCLUSIONS: Younger, generally healthier patients undergoing valve surgery are at greatest risk for developing late tamponade or pretamponade.


Subject(s)
Cardiac Surgical Procedures/adverse effects , Cardiac Tamponade/prevention & control , Drainage/methods , Pericardial Effusion/epidemiology , Postoperative Complications , Adult , Aged , Aged, 80 and over , Cardiac Tamponade/epidemiology , Cardiac Tamponade/etiology , Echocardiography , Female , Finland/epidemiology , Follow-Up Studies , Humans , Incidence , Male , Middle Aged , Pericardial Effusion/etiology , Pericardial Effusion/surgery , Prospective Studies , Risk Factors , Survival Rate/trends , Time Factors , Young Adult
15.
Prog Cardiovasc Dis ; 59(4): 380-388, 2017.
Article in English | MEDLINE | ID: mdl-28062268

ABSTRACT

The presentation of a patient with a pericardial effusion can range from an incidental finding to a life-threatening emergency. Accordingly, the causes of pericardial effusions are numerous and can generally be divided into inflammatory and non-inflammatory etiologies. For all patients with a suspected pericardial effusion, echocardiography is essential to define the location and size of an effusion. In pericardial tamponade, the hemodynamics relate to decreased pericardial compliance, ventricular interdependence, and an inspiratory decrease in the pressure gradient for left ventricular filling. Echocardiography provides insight into the pathophysiologic alterations, primarily through an assessment of chamber collapse, inferior vena cava plethora, and marked respiratory variation in mitral and tricuspid inflow. Once diagnosed, pericardiocentesis is performed in patients with tamponade, preferably with echocardiographic guidance. With a large effusion but no tamponade, pericardiocentesis is rarely needed for diagnostic purposes, though is performed if there is concern for a bacterial infection. In patients with malignancy, pericardial window is preferred given the risk for recurrence. Finally, large effusions can progress to tamponade, but can generally be followed closely until the extent of the effusion facilitates safe pericardiocentesis.


Subject(s)
Cardiac Tamponade , Echocardiography/methods , Pericardial Effusion , Pericardiocentesis/methods , Cardiac Tamponade/diagnosis , Cardiac Tamponade/etiology , Cardiac Tamponade/prevention & control , Disease Management , Hemodynamics , Humans , Pericardial Effusion/complications , Pericardial Effusion/diagnosis , Pericardial Effusion/physiopathology , Pericardial Effusion/therapy
16.
Interact Cardiovasc Thorac Surg ; 22(5): 641-6, 2016 05.
Article in English | MEDLINE | ID: mdl-26819273

ABSTRACT

OBJECTIVES: It is reported that creating a window from the posterior pericardium into the left pleural cavity during coronary bypass surgeries reduces postoperative late cardiac tamponades. Although late tamponades are more common after heart valve surgeries, this procedure is not generally performed. The present study investigated whether creating a window has a preventive effect on the formation of late cardiac tamponade after heart valve surgeries. METHODS: The study was conducted on all patients (n = 262) in whom one or more valves were replaced and who fulfilled the study criteria between January 2010 and October 2014 in one centre. We began to create a posterior pericardial window in all valvular patients from March 2012. One hundred and thirty-five patients operated on before this date (Non-Window Group) and 127 patients after this date (Window Group) were compared for the development of late cardiac tamponade. RESULTS: There were no differences between the groups in terms of preoperative and intraoperative characteristics. Late pericardial tamponade was not observed in any patients from the Window Group, whereas it occurred in 7 (5.2%) patients from the Non-Window Group (P = 0.015). Three patients died in total; all 3 were from the Non-Window Group. One of the mortalities was associated with tamponade. CONCLUSIONS: Creating a pericardial window may reduce late cardiac tamponade events/episodes, which may be a fatal complication in valve patients. We recommend performing this procedure by allocating some time during the surgical procedure in order to avoid tamponade.


Subject(s)
Cardiac Tamponade/prevention & control , Heart Valve Diseases/surgery , Heart Valve Prosthesis Implantation/adverse effects , Pericardial Window Techniques , Pericardium/surgery , Pleural Cavity/surgery , Aged , Cardiac Tamponade/etiology , Female , Follow-Up Studies , Humans , Male , Middle Aged , Retrospective Studies , Treatment Outcome
19.
Heart ; 101(21): 1711-6, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26076938

ABSTRACT

OBJECTIVES: Pericardial effusion is common after cardiac surgery. Growing evidence suggests that colchicine may be useful for acute pericarditis, but its efficacy in reducing pericardial effusion volume postoperatively has not been assessed. METHODS: This randomised, double-blind, placebo-controlled study conducted in 10 centres in France included 197 patients at high risk of tamponade (ie, with moderate to large-sized persistent effusion (echocardiography grades 2, 3 or 4 on a scale of 0-4)) at 7-30 days after cardiac surgery. Patients were randomly assigned to receive colchicine, 1 mg daily (n=98), or a matching placebo (n=99). The main end point was change in pericardial effusion grade after 14-day treatment. Secondary end points included frequency of late cardiac tamponade. RESULTS: The placebo and the colchicine groups showed a similar mean baseline pericardial effusion grade (2.9±0.8 vs 3.0±0.8) and similar mean decrease from baseline after treatment (-1.1±1.3 vs -1.3±1.3 grades). The mean difference in grade decrease between groups was -0.19 (95% CI -0.55 to 0.16, p=0.23). In total, 13 cases of cardiac tamponade occurred during the 14-day treatment (7 and 6 in the placebo and colchicine groups, respectively; p=0.80). At 6-month follow-up, all patients were alive and had undergone a total of 22 (11%) drainages: 14 in the placebo group and 8 in the colchicine group (p=0.20). CONCLUSIONS: In patients with pericardial effusion after cardiac surgery, colchicine administration does not reduce the effusion volume or prevent late cardiac tamponade. CLINICAL TRIAL REG NO: NCT01266694.


Subject(s)
Cardiac Tamponade , Colchicine , Pericardial Effusion , Postoperative Complications , Aged , Cardiac Surgical Procedures/adverse effects , Cardiac Tamponade/diagnosis , Cardiac Tamponade/etiology , Cardiac Tamponade/prevention & control , Colchicine/administration & dosage , Colchicine/adverse effects , Double-Blind Method , Drug Monitoring/methods , Echocardiography/methods , Female , Humans , Male , Middle Aged , Pericardial Effusion/diagnosis , Pericardial Effusion/drug therapy , Pericardial Effusion/etiology , Pericardial Effusion/physiopathology , Postoperative Complications/diagnosis , Postoperative Complications/drug therapy , Postoperative Complications/physiopathology , Treatment Outcome , Tubulin Modulators/administration & dosage , Tubulin Modulators/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL
...